Plus Therapeutics宣布与联合健康保险达成中枢神经系统癌症诊断工具包的全国覆盖协议-动脉网

Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit

benzinga 等信源发布 2025-09-25 07:31



可切换为仅中文







CNSide Diagnostics

中枢神经系统诊断

, a wholly-owned subsidiary of

，一家全资子公司 của

Plus Therapeutics

_plus 疗法_

, Inc.

公司

(NASDAQ:

（纳斯达克：

PSTV

), has signed a national agreement with

），已与签署了全国协议

UnitedHealthcare insurance company

联合健康保险公司

, a unit of

，一个单位的

UnitedHealth Group Inc.

联合健康集团

(NYSE:

（纽约证券交易所：

UNH

联合国教科文组织（UNH）

）。

Effective September 15, the agreement covers over 51 million people throughout the United States, providing the CNSide Cerebrospinal Fluid (CSF) Tumor Cell Enumeration

自9月15日起，该协议覆盖美国超过5100万人，提供CNSide脑脊液（CSF）肿瘤细胞计数服务。

laboratory developed test (LDT)

实验室自建检测（LDT）

。

The CNSide CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases.

CNSide CSF分析平台支持对软脑膜转移患者进行快速诊断、治疗监测和治疗指导。

The superior clinical utility of CNSide over standard of care has been shown in 9 peer-reviewed publications, the FORESEE clinical trial, and has been validated in the market through real-world use.

CNSide优于标准护理的卓越临床效用已在9篇同行评审的出版物和FORESEE临床试验中得到展示，并通过真实世界的使用在市场上得到了验证。

Also Read:

另请阅读：

Why Plus Therapeutics (PSTV) Shares Are Exploding Higher

为什么Plus Therapeutics（PSTV）的股价正在飙升

More than 11,000 CNSide tests have been performed at over 120 U.S. cancer institutions since 2020, delivering high sensitivity (92%) and specificity (95%), while influencing treatment decisions in 90% of cases.

自2020年以来，已有超过11,000例CNSide测试在美国120多家癌症机构进行，检测灵敏度高达92%，特异性达95%，并在90%的病例中影响了治疗决策。

This test is available exclusively through

本测试仅通过以下方式提供

CNSide Diagnostics

中枢神经系统诊断

, as a testing service provided to health care professionals in the U.S.

，作为提供给美国医疗保健专业人士的测试服务

Last week, CNSide Diagnostics received a certificate of accreditation from CMS for its lab

上周，CNSide诊断公司收到了CMS为其实验室颁发的认可证书

located in Houston, Texas

位于德克萨斯州休斯顿市

。

Following the recent planned laboratory audit, a certificate of accreditation deems the lab compliant with Clinical Laboratory Improvement Amendments regulations enforced by the Centers for Medicare & Medicaid Services, which are federal standards for laboratories performing testing on human specimens..

在最近计划的实验室审核之后，认可证书认定该实验室符合由美国医疗保险和医疗补助服务中心执行的《临床实验室改进修正案》法规，这些法规是针对进行人体样本检测的实验室的联邦标准。

The certification ensures laboratories meet all requirements for proficiency testing, personnel qualifications, and quality control.

该认证确保实验室满足能力测试、人员资格和质量控制的所有要求。

On Monday, Plus Therapeutics received notice of an additional advance payment from the Cancer Prevention and

周一，Plus Therapeutics收到了来自癌症预防机构的额外预付款通知。

Research Institute of Texas (CPRIT

德克萨斯州研究机构 (CPRIT)

）。

The $1.9 million payment is part of the company’s previously awarded $17.6 million grant and is the second non-dilutive financing received from CPRIT following the $1.6 million receipt announced in July 2025.

这笔190万美元的付款是该公司先前获得的1760万美元资助的一部分，也是继2025年7月宣布收到160万美元后，从CPRIT获得的第二笔非稀释性融资。

PSTV Price Action:

PSTV价格走势：

Plus Therapeutics shares were down 2.03% at $0.39 during premarket trading on Thursday. The stock is trading near its 52-week low of $0.16

Plus Therapeutics的股票在周四盘前交易中下跌2.03%，至0.39美元。该股交易接近其52周低点0.16美元。

, according to Benzinga Pro data

，根据Benzinga Pro数据

。